We are live on
!
Find out more
SA
Sovran Advisors Portfolio holdings
AUM
$1.34B
1-Year Est. Return
21.63%
This Fund
S&P 500
This Quarter
Est. Return
-2.44%
1 Year Est. Return
+21.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$770M
AUM Growth
+$68.8M
(+9.8%)
Cap. Flow
+$130M
Cap. Flow
% of AUM
16.87%
Top 10 Holdings %
Top 10 Hldgs %
19.85%
Holding
481
New
73
Increased
256
Reduced
119
Closed
26
Avg Time Held
0.8
quarters
Top 10 Avg Time Held
0.8
quarters
Top 20 Avg Time Held
0.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$7.21M |
| 2 |
Apple
AAPL
|
+$6.33M |
| 3 |
Ionis Pharmaceuticals
IONS
|
+$5.14M |
| 4 |
Microsoft
MSFT
|
+$5M |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Dynamic Income Fund
PDI
|
+$2.67M |
| 2 |
Johnson & Johnson
JNJ
|
+$2.63M |
| 3 |
Celldex Therapeutics
CLDX
|
+$2.6M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$2.6M |
| 5 |
iShares MSCI EAFE Growth ETF
EFG
|
+$2.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 72.84% |
| 2 | Technology | 9.26% |
| 3 | Healthcare | 4.68% |
| 4 | Consumer Discretionary | 3.53% |
| 5 | Financials | 2.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
426
Clorox
CLX
$10.2B
| $232K | 0.03% |
1,661
+18
| +1% | +$2.75K |
2024 Q4
1 quarter
|
|
427
Celanese
CE
$4.91B
| $232K | 0.03% |
+5,787
| New | +$361K |
2025 Q1
0 quarters
|
|
428
NextEra Energy
NEE
$163B
| $231K | 0.03% |
+3,484
| New | +$246K |
2025 Q1
0 quarters
|
|
429
Hartford Multifactor US Equity ETF
ROUS
$772M
| $226K | 0.03% |
4,702
-4,350
| -48% | -$226K |
2024 Q4
1 quarter
|
|
430
S&P Global
SPGI
$121B
| $225K | 0.03% |
+487
| New | +$249K |
2025 Q1
0 quarters
|
|
431
BP
BP
$125B
| $225K | 0.03% |
7,952
+454
| +6% | +$14.8K |
2024 Q4
1 quarter
|
|
432
State Street Multi-Asset Real Return ETF
RLY
$1.44B
| $221K | 0.03% |
+7,968
| New | +$223K |
2025 Q1
0 quarters
|
|
433
Invesco S&P 500 Revenue ETF
RWL
$10.1B
| $219K | 0.03% |
+2,337
| New | +$236K |
2025 Q1
0 quarters
|
|
434
Vanguard Total International Stock ETF
VXUS
$163B
| $217K | 0.03% |
3,541
+100
| +3% | +$6.18K |
2024 Q4
1 quarter
|
|
435
Columbia India Consumer ETF
INCO
$209M
| $216K | 0.03% |
3,457
-250
| -7% | -$15K |
2024 Q4
1 quarter
|
|
436
iShares International Dividend Growth ETF
IGRO
$1.27B
| $216K | 0.03% |
+2,981
| New | +$211K |
2025 Q1
0 quarters
|
|
437
Shopify
SHOP
$227B
| $215K | 0.03% |
+2,565
| New | +$280K |
2025 Q1
0 quarters
|
|
438
Cigna
CI
$74.7B
| $214K | 0.03% |
+649
| New | +$196K |
2025 Q1
0 quarters
|
|
439
Duke Energy
DUK
$92.2B
| $214K | 0.03% |
+1,757
| New | +$200K |
2025 Q1
0 quarters
|
|
440
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.63B
| $213K | 0.03% |
6,194
-9,559
| -61% | -$396K |
2024 Q4
1 quarter
|
|
441
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.3B
| $210K | 0.03% |
4,366
+701
| +19% | +$38.2K |
2024 Q4
1 quarter
|
|
442
Honeywell
HON
$65.7B
| $208K | 0.03% |
+1,125
| New | +$228K |
2025 Q1
0 quarters
|
|
443
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$5.84B
| $208K | 0.03% |
2,218
-175
| -7% | -$16.8K |
2024 Q4
1 quarter
|
|
444
DuPont de Nemours
DD
$17.5B
| $208K | 0.03% |
+2,749
| New | +$268K |
2025 Q1
0 quarters
|
|
445
iShares U.S. Thematic Rotation Active ETF
THRO
$7.51B
| $207K | 0.03% |
+6,816
| New | +$229K |
2025 Q1
0 quarters
|
|
446
iShares Core S&P Total US Stock Market ETF
ITOT
$97.8B
| $207K | 0.03% |
+1,802
| New | +$232K |
2025 Q1
0 quarters
|
|
447
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.53B
| $207K | 0.03% |
9,242
| – | – |
2024 Q4
1 quarter
|
|
448
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.27B
| $203K | 0.03% |
+8,965
| New | +$205K |
2025 Q1
0 quarters
|
|
449
Capital Group Core Balanced ETF
CGBL
$7.82B
| $201K | 0.03% |
+6,730
| New | +$214K |
2025 Q1
0 quarters
|
|
450
Xtrackers US National Critical Technologies ETF
CRTC
$165M
| $201K | 0.03% |
+7,169
| New | +$227K |
2025 Q1
0 quarters
|
|
Similar funds
TIM
AFCM
ACM
DIP
CS
B
LIA
WTA
Sovran Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Sovran Advisors held 481 positions worth $770M, up 9.8% from $702M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Sovran Advisors deployed $130M of net new capital in Q1 2025, opening 73 new positions and adding to 256 existing holdings. Its largest new stake was Novo Nordisk: 36,559 shares worth $2.12M.
By sector, the portfolio is most concentrated in Miscellaneous at 73% of assets, down from 75% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was PIMCO Dynamic Income Fund, an estimated $2.67M trimmed.
- Sovran Advisors's largest Q1 2025 buy was Novo Nordisk: 36,559 shares worth $2.12M.
- Sovran Advisors added most to Qualcomm in Q1 2025, an estimated $7.21M increase.
- Sovran Advisors's biggest Q1 2025 reduction was PIMCO Dynamic Income Fund, cutting an estimated $2.67M.
- Sovran Advisors fully exited Celldex Therapeutics in Q1 2025, selling an estimated $2.6M.
- Sovran Advisors's ten largest holdings make up 20% of its $770M portfolio in Q1 2025.
- Sovran Advisors opened 73 new positions and closed 26 in Q1 2025.
- Sovran Advisors's portfolio value rose 9.8% quarter-over-quarter to $770M.
Based on Sovran Advisors's 13F filing for Q1 2025, filed 25 Apr 2025.